| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.22 | 0.2 |